Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Williams

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Plos One|September 23, 2015
Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human CardiomyocytesHelen P McWilliams-Koeppen, James S Foster, Nicole Hackenbrack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast CancerHatem Soliman, Deanna Hogue, Hyo Han, et al.
Cytotherapy|October 18, 2017
Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damageYi Lin, Marta Marin-Argany, Christopher J Dick, et al.
Clinical Breast Cancer|August 13, 2021
MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed CellularityR Jared Weinfurtner, Natarajan Raghunand, Olya Stringfield, et al.
Annals of Internal Medicine|June 6, 2022
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled TrialMatthew G Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.
Journal of Breast Imaging|January 23, 2023
Quantitative Changes in Intratumoral Habitats on MRI Correlate With Pathologic Response in Early-stage ER/PR+ HER2- Breast Cancer Treated With Preoperative Stereotactic Ablative Body RadiotherapyR Jared Weinfurtner, Mahmoud Abdalah, Olya Stringfield, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2023
Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled TrialYanfen Guan, Amy Puenpatom, Matthew G Johnson, et al.
Human Vaccines & Immunotherapeutics|January 17, 2019
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adultsHelen L Stacey, Jeffrey Rosen, James T Peterson, et al.
Nature Medicine|March 18, 2023
Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trialHatem Soliman, Deanna Hogue, Hyo Han, et al.
RMD Open|February 28, 2023
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatmentPeter Kamenicky, Karine Briot, Maria Luisa Brandi, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Plos One|September 23, 2015
Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human CardiomyocytesHelen P McWilliams-Koeppen, James S Foster, Nicole Hackenbrack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2020
A Phase I Trial of Talimogene Laherparepvec in Combination with Neoadjuvant Chemotherapy for the Treatment of Nonmetastatic Triple-Negative Breast CancerHatem Soliman, Deanna Hogue, Hyo Han, et al.
Cytotherapy|October 18, 2017
Mesenchymal stromal cells protect human cardiomyocytes from amyloid fibril damageYi Lin, Marta Marin-Argany, Christopher J Dick, et al.
Clinical Breast Cancer|August 13, 2021
MRI Response to Pre-operative Stereotactic Ablative Body Radiotherapy (SABR) in Early Stage ER/PR+ HER2- Breast Cancer correlates with Surgical Pathology Tumor Bed CellularityR Jared Weinfurtner, Natarajan Raghunand, Olya Stringfield, et al.
Annals of Internal Medicine|June 6, 2022
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled TrialMatthew G Johnson, Amy Puenpatom, Pablo Andrés Moncada, et al.
Journal of Breast Imaging|January 23, 2023
Quantitative Changes in Intratumoral Habitats on MRI Correlate With Pathologic Response in Early-stage ER/PR+ HER2- Breast Cancer Treated With Preoperative Stereotactic Ablative Body RadiotherapyR Jared Weinfurtner, Mahmoud Abdalah, Olya Stringfield, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2023
Impact of Molnupiravir Treatment on Patient-Reported COVID-19 Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled TrialYanfen Guan, Amy Puenpatom, Matthew G Johnson, et al.
Human Vaccines & Immunotherapeutics|January 17, 2019
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adultsHelen L Stacey, Jeffrey Rosen, James T Peterson, et al.
Nature Medicine|March 18, 2023
Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trialHatem Soliman, Deanna Hogue, Hyo Han, et al.
RMD Open|February 28, 2023
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatmentPeter Kamenicky, Karine Briot, Maria Luisa Brandi, et al.
Pageof 14